doi: 10.1001/jamainternmed.2013.379.
The frequency and characteristics of dietary supplement recalls in the United States
- PMID: 23589151
- DOI: 10.1001/jamainternmed.2013.379
Item in Clipboard
The frequency and characteristics of dietary supplement recalls in the United States
JAMA Intern Med.
.
No abstract available
Comment in
-
How can we know if supplements are safe if we do not know what is in them?: Comment on "The frequency and characteristics of dietary supplement recalls in the United States".JAMA Intern Med. 2013 May 27;173(10):928. doi: 10.1001/jamainternmed.2013.415. JAMA Intern Med. 2013. PMID: 23588233 No abstract available.
-
Illegally marketed drug ingredients are not dietary supplements.JAMA Intern Med. 2013 Dec 9-23;173(22):2090-1. doi: 10.1001/jamainternmed.2013.10417. JAMA Intern Med. 2013. PMID: 24322462 No abstract available.
-
Illegally marketed drug ingredients are not dietary supplements--reply.JAMA Intern Med. 2013 Dec 9-23;173(22):2091. doi: 10.1001/jamainternmed.2013.10386. JAMA Intern Med. 2013. PMID: 24322464 No abstract available.
Similar articles
-
How can we know if supplements are safe if we do not know what is in them?: Comment on "The frequency and characteristics of dietary supplement recalls in the United States".JAMA Intern Med. 2013 May 27;173(10):928. doi: 10.1001/jamainternmed.2013.415. JAMA Intern Med. 2013. PMID: 23588233 No abstract available.
-
The epidemiology of drug recalls in the United States.Arch Intern Med. 2012 Jul 23;172(14):1109-10. doi: 10.1001/archinternmed.2012.2013. Arch Intern Med. 2012. PMID: 22664942 No abstract available.
-
Presence of banned drugs in dietary supplements following FDA recalls.JAMA. 2014 Oct 22-29;312(16):1691-3. doi: 10.1001/jama.2014.10308. JAMA. 2014. PMID: 25335153 No abstract available.
-
Dietary supplements and lessons to be learned from GRAS.Regul Toxicol Pharmacol. 2000 Feb;31(1):68-76. doi: 10.1006/rtph.1999.1369. Regul Toxicol Pharmacol. 2000. PMID: 10715226 Review.
-
Marketing dietary supplements in the United States: a review of the requirements for new dietary ingredients.Toxicology. 2006 Apr 3;221(1):4-8. doi: 10.1016/j.tox.2006.01.010. Epub 2006 Feb 21. Toxicology. 2006. PMID: 16497425 Review.
Cited by
-
Cholestasis Linked to Bodybuilding Supplements: Exploring the Risks of Contamination.Case Reports Hepatol. 2024 May 24;2024:5112461. doi: 10.1155/2024/5112461. eCollection 2024. Case Reports Hepatol. 2024. PMID: 38826497 Free PMC article.
-
A content analysis of marketing on the packages of dietary supplements for weight loss and muscle building.Prev Med Rep. 2021 Jul 23;23:101504. doi: 10.1016/j.pmedr.2021.101504. eCollection 2021 Sep. Prev Med Rep. 2021. PMID: 34367889 Free PMC article.
-
Drug and medical device product failures and the stability of the pharmaceutical supply chain.J Am Pharm Assoc (2003). 2021 Jan-Feb;61(1):e119-e122. doi: 10.1016/j.japh.2020.07.005. Epub 2020 Aug 1. J Am Pharm Assoc (2003). 2021. PMID: 32753251 Free PMC article.
-
Outbreak of Severe Hypoglycemia After Ingestion of a Male Enhancement Supplement - Virginia, August-November 2019.MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):740-743. doi: 10.15585/mmwr.mm6924a3. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32555139 Free PMC article.
-
Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review.Adv Ther. 2020 Feb;37(2):656-670. doi: 10.1007/s12325-019-01211-1. Epub 2020 Jan 9. Adv Ther. 2020. PMID: 31919792 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
